Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
N ViñolasSpanish Lung Cancer Group

Abstract

New therapeutic approaches are being developed based on the findings that several genetic abnormalities underlying NSCLC could influence chemosensitivity. In this study, we assessed whether the presence of polymorphisms in ERCC1, XPD, RRM1 and MDR1 genes can affect the efficacy and the tolerability of cisplatin and vinorelbine in NSCLC patients. Eligible patients had histological confirmed stage IV or IIIB (with malignant pleural effusion) non-small-cell lung cancer (NSCLC) previously untreated with chemotherapy; World Health Organization performance status (PS) 0-1. Patients received intravenous doses of vinorelbine 25 mg/m² on day 1 and 8 and cisplatin 75 mg/m² on day 1, every 21 days, for a maximum of eight cycles. 94 patients were included. Median age was 61 years; 84% were male; WHO performance status (PS) was 0 in 24%; and 88% of patients had stage IV disease. The median number of cycles was 6. Overall median survival was 10.92 months (95% CI 9.0-12.9). Overall median time to progression was 5.89 months (95% CI 5.2-6.6). Results of the multivariate analysis for time to progression showed that ECOG 0 (hazard ratio [HR] ECOG 1 vs. ECOG 0, 1.74; p=0.036), MDR13435CC (HR CT vs. CC, 2.01; p=0.017; HR TT vs. CC, 1.54; p=0.22), ...Continue Reading

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Aug 2, 1989·Journal of the National Cancer Institute·S L LaiA F Gazdar
Oct 5, 2001·Journal of the National Cancer Institute·Z M WangL C Panasci
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G V ScagliottiUNKNOWN Italian Lung Cancer Project
Apr 11, 2003·The New England Journal of Medicine·Asra SiddiquiSanjay M Sisodiya
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rafael RosellUNKNOWN Spanish Lung Cancer Group
May 14, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jeong-Seon RyuTae-Sook Hwang
Jun 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sarada GurubhagavatulaDavid C Christiani
Jul 28, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D IslaP Lianes
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wei ZhouDavid C Christiani
Jan 13, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R de las PeñasR Rosell
Feb 16, 2006·Japanese Journal of Clinical Oncology·Ji Woong SohnJae Yong Park
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerold BeplerGeorge Simon
May 10, 2007·British Journal of Haematology·Gabriele BudaMario Petrini
Sep 14, 2007·Respiration; International Review of Thoracic Diseases·Ji-hong PanQing-zhong Yu
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tristan M SissungWilliam D Figg
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin BornhäuserGerhard Ehninger
Oct 7, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H ChangH C Chung
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory J AuneYves Pommier
Mar 17, 2009·Biochimica Et Biophysica Acta·King Leung Fung, Michael M Gottesman
Sep 24, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Cielito C Reyes-GibbySanjay Shete
Jan 19, 2010·Genetics and Molecular Research : GMR·M TaheriR Omranipour

❮ Previous
Next ❯

Citations

Jan 1, 2011·Pharmacogenomics and Personalized Medicine·Alec VaeziLaura J Niedernhofer
Dec 18, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yanlong Yang, Lei Xian
Jul 13, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Xia WenLauren M Aleksunes
Aug 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Joel L WeissfeldMarjorie Romkes
Jun 19, 2012·Archives of Medical Research·Paolo PellegrinoEmilio Clementi
Aug 21, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hairong QiuKourong Miao
Dec 10, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·R MlakT Małecka-Massalska
Mar 13, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ik-Chan SongHwan-Jung Yun
Apr 30, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chuan-Xiang MaHai-Ying Wang
Sep 18, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jian-Huang LiJun Cao
Aug 20, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ying NiHairong Qiu
Jan 8, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dao-Qi ZhuPing Liu
Apr 24, 2013·Asian Pacific Journal of Tropical Medicine·Xiao-Feng LiBao-Rong Chi
Aug 9, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Pérez-RamírezMiguel Ÿngel Calleja-Hernández
May 7, 2013·Cancer Chemotherapy and Pharmacology·R SalazarL Paz-Ares

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.